The 3rd RNA- Targeted Drug Discovery Summit returns as the most ... but also to drive forward optimized strategies to improve target selection and gain pre-clinical proof of concept to drive ...

scale, capture and characterize drug–target interactions efficiently, facilitating faster decision-making in drug discovery projects.

Trypanosomes are parasites that cause sleeping sickness, Chagas disease, and various animal diseases. Diagnosis and treatment remain complex and no effective vaccine has been developed. A better ...

By solving one of biology’s most fundamental problems, AlphaFold demonstrated the potential of AI to advance drug discovery ... This includes early discovery and target identification uses—areas where ...

For example, AI-backed drug discovery supports the approval of customized cancer therapies that target undruggable mutations. Some firms can use generative AI to uncover compounds that mitigate the ...

At a time when the previously untapped drug discovery opportunity promised within RNA opens up, the 2 nd RNA- Targeted Drug Discovery Summit returns to reunite the leading minds from large ...

A new study from the Kowalinski group at EMBL Grenoble characterised the structure of an important trypanosomal protein complex, potentially paving the way for novel drug discovery in the future.